Evaluation of a bidirectional causal association between cardiovascular diseases and pneumonia: a Mendelian randomization study - Scorecard - MDSpire

Evaluation of a bidirectional causal association between cardiovascular diseases and pneumonia: a Mendelian randomization study

  • By

  • Yeshen Zhang

  • Haobin Liu

  • Yining Dai

  • Fei Ye

  • Wenzhi Luo

  • Shan Tu

  • Weikun Chen

  • Siyu Kong

  • Yu He

  • Ning Tan

  • Zhihui Zhang

  • Pengcheng He

  • Yuanhui Liu

  • February 13, 2024

  • 0 min

Share

Clinical Scorecard: Investigation of the Bidirectional Causal Link Between Cardiovascular Diseases and Pneumonia Through Mendelian Randomization Analysis

At a Glance

CategoryDetail
ConditionCardiovascular diseases (CVDs) and pneumonia
Key MechanismsGenetic correlation and causal association assessed via Mendelian randomization; ischaemic stroke causally linked to pneumonia mediated by deep venous thrombosis
Target PopulationPatients with cardiovascular diseases, especially ischaemic stroke
Care SettingClinical settings managing cardiovascular diseases and pneumonia risk

Key Highlights

  • Significant positive genetic correlation exists between CVDs and pneumonia.
  • Ischaemic stroke is causally associated with increased risk of pneumonia, including bacterial and pneumococcal pneumonia.
  • No evidence supports a causal effect of pneumonia on cardiovascular diseases.

Guideline-Based Recommendations

Diagnosis

  • Consider genetic risk factors when evaluating patients with CVDs for pneumonia risk.
  • Screen for deep venous thrombosis in patients with ischaemic stroke to assess pneumonia risk.

Management

  • Implement thrombosis risk screening as a strategy to reduce pneumonia incidence in patients with ischaemic stroke.
  • Monitor and manage pneumonia proactively in patients with ischaemic stroke.

Monitoring & Follow-up

  • Regularly monitor patients with ischaemic stroke for signs of pneumonia and thrombosis.
  • Use genetic and clinical data to guide risk stratification for pneumonia in CVD patients.

Risks

  • Increased risk of pneumonia following ischaemic stroke mediated by thrombosis.
  • No increased cardiovascular risk causally linked to pneumonia based on current genetic evidence.

Patient & Prescribing Data

Patients with ischaemic stroke and other cardiovascular diseases

Focus on thrombosis risk reduction may decrease pneumonia incidence; no direct causal treatment implications for pneumonia affecting CVDs identified.

Clinical Best Practices

  • Incorporate thrombosis risk screening in post-stroke care protocols to mitigate pneumonia risk.
  • Use Mendelian randomization findings to inform clinical decision-making regarding pneumonia prevention in CVD patients.
  • Maintain vigilance for pneumonia development in patients with ischaemic stroke, especially those with deep venous thrombosis.

References

Original Source(s)

Related Content